Home > Investor > Financial Highlights > Revenues by country

Revenues by country

Distribution of sales revenues by geographic region 
 %
Europe 33
Bulgaria  65
Other 2

The contribution of sales in Bulgaria to the consolidated sales revenue in H1 2018 amounted to 65%, increasing by 10% compared to H1 2017. Sopharma had a 3.5% share of the Bulgarian pharmaceutical market in terms of value and a 12% share in term of sold quantity (units). The position of the main competitors of the Company in the country are as follows:

  • Novartis: 7% (4% in units)
  • Roche: 6% (0.3% in units),
  • Actavis: 5% (10% in units)
  • GlaxoSmithKlein: 4% (3% in units)
  • Abbvie: 3.5% (0% in units)
  • Sanofi-Aventis: 3.6% (3% in units)
  • Astra Zeneca: 3% (1% in units)
  • Pfizer: 3.6% (1% in units)
  • Merck: 2.7% (1% in units)